Clinical research
Redo surgery risk in patients with cardiac prosthetic valve dysfunction
 
More details
Hide details
Submission date: 2010-06-08
Final revision date: 2010-09-04
Acceptance date: 2010-09-04
Online publication date: 2011-05-17
Publication date: 2011-05-17
 
Arch Med Sci 2011;7(2):271–277
 
KEYWORDS
TOPICS
ABSTRACT
Introduction : The aim of the study was to analyse the risk factors of early and late mortality in patients undergoing the first reoperation for prosthetic valve dysfunction.
Material and methods : A retrospective observational study was performed in 194 consecutive patients (M = 75, F = 119; mean age 53.2 ±11 years) with a mechanical prosthetic valve (n = 103 cases; 53%) or bioprosthesis (91; 47%). Univariate and multivariate Cox statistical analysis was performed to determine risk factors of early and late mortality.
Results : The overall early mortality was 18.6%: 31.4% in patients with symptoms of NYHA functional class III-IV and 3.4% in pts in NYHA class I-II. Multivariate analysis identified symptoms of NYHA class III-IV and endocarditis as independent predictors of early mortality. The overall late mortality (> 30 days) was 8.2% (0.62% year/patient). Multivariate analysis identified age at the time of reoperation as a strong independent predictor of late mortality.
Conclusions : Reoperation in patients with prosthetic valves, performed urgently, especially in patients with symptoms of NYHA class III-IV or in the case of endocarditis, bears a high mortality rate. Risk of planned reoperation, mostly in patients with symptoms of NYHA class I-II, does not differ from the risk of the first operation.
eISSN:1896-9151
ISSN:1734-1922